Alder Biopharma (ALDR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -176,345 | -117,934 | -296,429 | -216,340 | -155,420 |
| Depreciation Amortization | 1,070 | 533 | 2,567 | 2,145 | 1,608 |
| Accounts payable and accrued liabilities | -1,257 | 6,392 | 1,273 | 8,186 | 8,026 |
| Other Working Capital | 17,790 | 33,249 | 8,258 | 9,587 | 9,306 |
| Other Operating Activity | 24,868 | 3,184 | 33,481 | 18,422 | 9,954 |
| Operating Cash Flow | $-133,874 | $-74,576 | $-250,850 | $-178,000 | $-126,526 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,039 | -303 | -3,136 | -1,337 | -277 |
| Purchase Of Investment | -64,022 | -64,022 | -522,795 | -522,795 | -487,031 |
| Sale Of Investment | 65,290 | 36,290 | 404,813 | 342,813 | 276,184 |
| Investing Cash Flow | $229 | $-28,035 | $-121,118 | $-181,319 | $-211,124 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 277,656 | 277,656 | 277,656 |
| Common Stock Issued | 160,499 | 159,737 | 2,571 | 1,467 | 1,142 |
| Other Financing Activity | 0 | 0 | 97,710 | 97,710 | 97,710 |
| Financing Cash Flow | $160,499 | $159,737 | $377,937 | $376,833 | $376,508 |
| Beginning Cash Position | 92,865 | 92,865 | 86,896 | 86,896 | 86,896 |
| End Cash Position | 119,719 | 149,991 | 92,865 | 104,410 | 125,754 |
| Net Cash Flow | $26,854 | $57,126 | $5,969 | $17,514 | $38,858 |
| Free Cash Flow | |||||
| Operating Cash Flow | -133,874 | -74,576 | -250,850 | -178,000 | -126,526 |
| Capital Expenditure | -1,039 | -303 | -3,136 | -1,337 | -277 |
| Free Cash Flow | -134,913 | -74,879 | -253,986 | -179,337 | -126,803 |